Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ambroxol-theophylline-7-acetate
1. Ambroxol Acefyllinate
2. Ambromucil
3. Broncomnes
4. Surfolase
5. 96989-76-3
6. Ambroxol Theophyllinacetate
7. 179118-73-1
8. Ambroxol-theophylline-7-acetate
9. Ambroxol Theophyllinate
10. 0hm1e174tn
11. 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic Acid
12. Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, Trans-, Mono(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7h-purine-7-acetate) (salt)
13. Unii-0hm1e174tn
14. Schembl1650322
15. Chembl4297663
16. Dtxsid60914235
17. Glxc-26022
18. Bcp28655
19. Ambroxol Acefyllinate [mart.]
20. Akos015899892
21. Ambroxol Acefyllinate [who-dd]
22. Db13141
23. Ambroxol Theophyllinate [who-dd]
24. Ambromucil Pound>>ambroxol-theophylline-7-acetate
25. Q19607226
26. (1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetic Acid--4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol (1/1)
27. 7h-purine-7-acetic Acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, Compd. With Trans-4-(((2-amino-3,5-dibromophenyl)methyl)amino)cyclohexanol (1:1)
Molecular Weight | 616.3 g/mol |
---|---|
Molecular Formula | C22H28Br2N6O5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 616.04674 g/mol |
Monoisotopic Mass | 614.04879 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 645 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Global Sales Information
Market Place
ABOUT THIS PAGE
79
PharmaCompass offers a list of Acebrophylline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acebrophylline manufacturer or Acebrophylline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acebrophylline manufacturer or Acebrophylline supplier.
PharmaCompass also assists you with knowing the Acebrophylline API Price utilized in the formulation of products. Acebrophylline API Price is not always fixed or binding as the Acebrophylline Price is obtained through a variety of data sources. The Acebrophylline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ambroxol-Theophylline-7-Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ambroxol-Theophylline-7-Acetate, including repackagers and relabelers. The FDA regulates Ambroxol-Theophylline-7-Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ambroxol-Theophylline-7-Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ambroxol-Theophylline-7-Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ambroxol-Theophylline-7-Acetate supplier is an individual or a company that provides Ambroxol-Theophylline-7-Acetate active pharmaceutical ingredient (API) or Ambroxol-Theophylline-7-Acetate finished formulations upon request. The Ambroxol-Theophylline-7-Acetate suppliers may include Ambroxol-Theophylline-7-Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Ambroxol-Theophylline-7-Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ambroxol-Theophylline-7-Acetate Drug Master File in Korea (Ambroxol-Theophylline-7-Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ambroxol-Theophylline-7-Acetate. The MFDS reviews the Ambroxol-Theophylline-7-Acetate KDMF as part of the drug registration process and uses the information provided in the Ambroxol-Theophylline-7-Acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ambroxol-Theophylline-7-Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ambroxol-Theophylline-7-Acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ambroxol-Theophylline-7-Acetate suppliers with KDMF on PharmaCompass.
A Ambroxol-Theophylline-7-Acetate written confirmation (Ambroxol-Theophylline-7-Acetate WC) is an official document issued by a regulatory agency to a Ambroxol-Theophylline-7-Acetate manufacturer, verifying that the manufacturing facility of a Ambroxol-Theophylline-7-Acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ambroxol-Theophylline-7-Acetate APIs or Ambroxol-Theophylline-7-Acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Ambroxol-Theophylline-7-Acetate WC (written confirmation) as part of the regulatory process.
click here to find a list of Ambroxol-Theophylline-7-Acetate suppliers with Written Confirmation (WC) on PharmaCompass.
Ambroxol-Theophylline-7-Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ambroxol-Theophylline-7-Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ambroxol-Theophylline-7-Acetate GMP manufacturer or Ambroxol-Theophylline-7-Acetate GMP API supplier for your needs.
A Ambroxol-Theophylline-7-Acetate CoA (Certificate of Analysis) is a formal document that attests to Ambroxol-Theophylline-7-Acetate's compliance with Ambroxol-Theophylline-7-Acetate specifications and serves as a tool for batch-level quality control.
Ambroxol-Theophylline-7-Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Ambroxol-Theophylline-7-Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ambroxol-Theophylline-7-Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ambroxol-Theophylline-7-Acetate EP), Ambroxol-Theophylline-7-Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ambroxol-Theophylline-7-Acetate USP).